🇺🇸 FDA
Pipeline program

VP-102 Cantharidin topical film forming solution

VP-102-105

Phase 2 other completed

Quick answer

VP-102 Cantharidin topical film forming solution for Common Wart is a Phase 2 program (other) at Verrica Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Verrica Pharmaceuticals
Indication
Common Wart
Phase
Phase 2
Modality
other
Status
completed

Clinical trials